| Emittent | Gattung | Typ | CUSIP/ISIN | Richtung | Bewertungsbasis | Handel | Bestand ($) | % NAV | Stück / Nennwert |
|---|---|---|---|---|---|---|---|---|---|
| Gesamt | 1.137.458.966 $ | 99,92 | 19.691.725 | ||||||
| JOHNSON & JOHNSON | JOHNSON JOHNSON | EC | 478160104 | Long | Börsenkurs (Stufe 1) | 255.484.677 $ | 22,44 | 1.005.964 | |
| ELI LILLY AND COMPANY | ELI LILLY CO | EC | 532457108 | Long | Börsenkurs (Stufe 1) | 253.226.060 $ | 22,25 | 211.122 | |
| MERCK & CO., INC. | MERCK CO INC | EC | 58933Y105 | Long | Börsenkurs (Stufe 1) | 51.774.064 $ | 4,55 | 402.911 | |
| BRISTOL-MYERS SQUIBB COMPANY | BRISTOL MYERS SQUIBB CO | EC | 110122108 | Long | Börsenkurs (Stufe 1) | 49.725.657 $ | 4,37 | 862.993 | |
| ROYALTY PHARMA PLC | ROYALTY PHARMA PLC | EC | G7709Q104 | Long | Börsenkurs (Stufe 1) | 49.346.478 $ | 4,34 | 880.087 | |
| VIATRIS INC. | VIATRIS INC | EC | 92556V106 | Long | Börsenkurs (Stufe 1) | 48.049.609 $ | 4,22 | 3.025.794 | |
| PFIZER INC. | PFIZER INC | EC | 717081103 | Long | Börsenkurs (Stufe 1) | 45.133.457 $ | 3,96 | 1.874.313 | |
| ZOETIS INC. | ZOETIS INC | EC | 98978V103 | Long | Börsenkurs (Stufe 1) | 42.416.155 $ | 3,73 | 590.261 | |
| JAZZ PHARMACEUTICALS PUBLIC LIMITED COMPANY | JAZZ PHARMACEUTICALS PLC | EC | G50871105 | Long | Börsenkurs (Stufe 1) | 39.283.652 $ | 3,45 | 163.023 | |
| ELANCO ANIMAL HEALTH INCORPORATED | ELANCO ANIMAL HEALTH INC | EC | 28414H103 | Long | Börsenkurs (Stufe 1) | 31.936.200 $ | 2,81 | 1.297.692 | |
| AXSOME THERAPEUTICS, INC. | AXSOME THERAPEUTICS INC | EC | 05464T104 | Long | Börsenkurs (Stufe 1) | 27.490.363 $ | 2,41 | 112.311 | |
| CORCEPT THERAPEUTICS INCORPORATED | CORCEPT THERAPEUTICS INC | EC | 218352102 | Long | Börsenkurs (Stufe 1) | 21.584.729 $ | 1,90 | 248.243 | |
| LIGAND PHARMACEUTICALS INCORPORATED | LIGAND PHARMACEUTICALS | EC | 53220K504 | Long | Börsenkurs (Stufe 1) | 16.458.806 $ | 1,45 | 52.070 | |
| Definium Therapeutics Inc | DEFINIUM THERAPEUTICS INC | EC | 24477V105 | Long | Börsenkurs (Stufe 1) | 15.807.086 $ | 1,39 | 336.035 | |
| Liquidia Corp | LIQUIDIA CORP | EC | 53635D202 | Long | Börsenkurs (Stufe 1) | 14.553.595 $ | 1,28 | 182.536 | |
| INDIVIOR PHARMACEUTICALS, INC. | INDIVIOR PHARMACEUTICALS INC | EC | 45579U109 | Long | Börsenkurs (Stufe 1) | 12.997.565 $ | 1,14 | 316.782 | |
| Crinetics Pharmaceuticals Inc | CRINETICS PHARMACEUTICALS INC | EC | 22663K107 | Long | Börsenkurs (Stufe 1) | 10.250.685 $ | 0,90 | 273.936 | |
| ORGANON & CO. | ORGANON CO | EC | 68622V106 | Long | Börsenkurs (Stufe 1) | 9.248.199 $ | 0,81 | 683.028 | |
| Edgewise Therapeutics Inc | EDGEWISE THERAPEUTICS INC | EC | 28036F105 | Long | Börsenkurs (Stufe 1) | 7.959.173 $ | 0,70 | 195.894 | |
| AMNEAL PHARMACEUTICALS, INC. | AMNEAL PHARMACEUTICALS INC | EC | 03168L105 | Long | Börsenkurs (Stufe 1) | 7.756.247 $ | 0,68 | 448.079 | |
| Enliven Therapeutics Inc | ENLIVEN THERAPEUTICS INC | EC | 29337E102 | Long | Börsenkurs (Stufe 1) | 7.177.826 $ | 0,63 | 141.435 | |
| SUPERNUS PHARMACEUTICALS, INC. | SUPERNUS PHARMACEUTICALS INC | EC | 868459108 | Long | Börsenkurs (Stufe 1) | 7.021.196 $ | 0,62 | 150.961 | |
| Tarsus Pharmaceuticals Inc | TARSUS PHARMACEUTICALS INC | EC | 87650L103 | Long | Börsenkurs (Stufe 1) | 6.469.351 $ | 0,57 | 102.786 | |
| Veradermics Inc | VERADERMICS INC | EC | 922967104 | Long | Börsenkurs (Stufe 1) | 6.400.871 $ | 0,56 | 52.065 | |
| Alumis Inc | ALUMIS INC | EC | 022307102 | Long | Börsenkurs (Stufe 1) | 6.233.601 $ | 0,55 | 221.521 | |
| NEKTAR THERAPEUTICS | NEKTAR THERAPEUTICS | EC | 640268306 | Long | Börsenkurs (Stufe 1) | 6.134.763 $ | 0,54 | 87.878 | |
| PRESTIGE CONSUMER HEALTHCARE INC. | PRESTIGE CONSUMER HEALTH | EC | 74112D101 | Long | Börsenkurs (Stufe 1) | 5.813.454 $ | 0,51 | 122.984 | |
| Trevi Therapeutics Inc | TREVI THERAPEUTICS INC | EC | 89532M101 | Long | Börsenkurs (Stufe 1) | 5.716.430 $ | 0,50 | 306.511 | |
| OCULAR THERAPEUTIX, INC. | OCULAR THERAPEUTIX INC | EC | 67576A100 | Long | Börsenkurs (Stufe 1) | 4.472.499 $ | 0,39 | 455.448 | |
| INNOVIVA, INC. | INNOVIVA INC | EC | 45781M101 | Long | Börsenkurs (Stufe 1) | 4.140.147 $ | 0,36 | 182.305 | |
| Amylyx Pharmaceuticals Inc | AMYLYX PHARMACEUTICALS INC | EC | 03237H101 | Long | Börsenkurs (Stufe 1) | 3.944.232 $ | 0,35 | 219.612 | |
| ANI PHARMACEUTICALS, INC. | ANI PHARMACEUTICALS INC | EC | 00182C103 | Long | Börsenkurs (Stufe 1) | 3.924.103 $ | 0,34 | 47.404 | |
| MBX Biosciences Inc | MBX BIOSCIENCES INC | EC | 55287L101 | Long | Börsenkurs (Stufe 1) | 3.822.434 $ | 0,34 | 69.247 | |
| HARMONY BIOSCIENCES HOLDINGS, INC. | HARMONY BIOSCIENCES HOLDINGS INC | EC | 413197104 | Long | Börsenkurs (Stufe 1) | 3.779.504 $ | 0,33 | 103.804 | |
| PERRIGO COMPANY PUBLIC LIMITED COMPANY | PERRIGO CO PLC | EC | G97822103 | Long | Börsenkurs (Stufe 1) | 3.735.496 $ | 0,33 | 359.528 | |
| HARROW, INC. | HARROW INC | EC | 415858109 | Long | Börsenkurs (Stufe 1) | 3.661.509 $ | 0,32 | 86.214 | |
| NUVATION BIO INC. | NUVATION BIO INC | EC | 67080N101 | Long | Börsenkurs (Stufe 1) | 3.598.854 $ | 0,32 | 633.601 | |
| XERIS BIOPHARMA HOLDINGS, INC. | XERIS BIOPHARMA HOLDINGS INC | EC | 98422E103 | Long | Börsenkurs (Stufe 1) | 3.552.128 $ | 0,31 | 448.501 | |
| Rapport Therapeutics Inc | RAPPORT THERAPEUTICS INC | EC | 75383L102 | Long | Börsenkurs (Stufe 1) | 3.105.248 $ | 0,27 | 74.520 | |
| Collegium Pharmaceutical, Inc. | COLLEGIUM PHARMACEUTICAL INC | EC | 19459J104 | Long | Börsenkurs (Stufe 1) | 3.049.379 $ | 0,27 | 84.237 | |
| EYEPOINT, INC. | EYEPOINT INC | EC | 30233G209 | Long | Börsenkurs (Stufe 1) | 2.926.624 $ | 0,26 | 204.659 | |
| AtaiBeckley Inc | ATAIBECKLEY INC | EC | 04650F101 | Long | Börsenkurs (Stufe 1) | 2.667.463 $ | 0,23 | 506.160 | |
| PACIRA BIOSCIENCES, INC. | PACIRA BIOSCIENCES INC | EC | 695127100 | Long | Börsenkurs (Stufe 1) | 2.590.480 $ | 0,23 | 102.108 | |
| WAVE Life Sciences Ltd | WAVE LIFE SCIENCES LTD | EC | Y95308105 | Long | Börsenkurs (Stufe 1) | 2.290.482 $ | 0,20 | 394.231 | |
| Maze Therapeutics Inc | MAZE THERAPEUTICS INC | EC | 578784100 | Long | Börsenkurs (Stufe 1) | 2.183.094 $ | 0,19 | 73.160 | |
| LB Pharmaceuticals Inc | LB PHARMACEUTICALS INC | EC | 50180M108 | Long | Börsenkurs (Stufe 1) | 2.050.280 $ | 0,18 | 63.173 | |
| BIOAGE Labs Inc | BIOAGE LABS INC | EC | 09077V100 | Long | Börsenkurs (Stufe 1) | 2.032.810 $ | 0,18 | 82.938 | |
| Septerna Inc | SEPTERNA INC | EC | 81734D104 | Long | Börsenkurs (Stufe 1) | 1.996.171 $ | 0,18 | 59.605 | |
| AMPHASTAR PHARMACEUTICALS, INC. | AMPHASTAR PHARMACEUTICALS INC | EC | 03209R103 | Long | Börsenkurs (Stufe 1) | 1.785.789 $ | 0,16 | 88.493 | |
| OMEROS CORPORATION | OMEROS CORP | EC | 682143102 | Long | Börsenkurs (Stufe 1) | 1.784.114 $ | 0,16 | 187.604 | |
| PHIBRO ANIMAL HEALTH CORPORATION | PHIBRO ANIMAL HEALTH CORP | EC | 71742Q106 | Long | Börsenkurs (Stufe 1) | 1.724.394 $ | 0,15 | 54.917 | |
| THERAVANCE BIOPHARMA, INC. | THERAVANCE BIOPHARMA INC | EC | G8807B106 | Long | Börsenkurs (Stufe 1) | 1.667.241 $ | 0,15 | 98.073 | |
| CORMEDIX INC. | CORMEDIX INC | EC | 21900C308 | Long | Börsenkurs (Stufe 1) | 1.492.748 $ | 0,13 | 190.159 | |
| PHATHOM PHARMACEUTICALS, INC. | PHATHOM PHARMACEUTICALS INC | EC | 71722W107 | Long | Börsenkurs (Stufe 1) | 1.443.310 $ | 0,13 | 133.024 | |
| Arvinas Inc | ARVINAS INC | EC | 04335A105 | Long | Börsenkurs (Stufe 1) | 1.397.368 $ | 0,12 | 168.155 | |
| Evolus Inc | EVOLUS INC | EC | 30052C107 | Long | Börsenkurs (Stufe 1) | 1.191.112 $ | 0,10 | 171.630 | |
| Gesamt | 1.137.458.966 $ | 99,92 | 19.691.725 |